Nuvation bio to present at the td cowen 45th annual health care conference

New york--(business wire)--nuvation bio inc. (nyse: nuvb), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that david hung, m.d., founder, president, and chief executive officer of nuvation bio, will present at the td cowen 45th annual health care conference on monday, march 3, 2025, at 3:10 p.m. et in boston, ma. a live webcast of the presentation will be available on the nuvation bio website at https://investors.nuvationbio.com/investo.
COWN Ratings Summary
COWN Quant Ranking